Loading evidence-driven research…
Loading evidence-driven research…
Herb Profile
Danshen/Salvia miltiorrhiza has pharmacology and clinical literature in cardiovascular contexts, but product and preparation differences require conservative interpretation.
Evidence level
Limited Human Evidence
Typical onset
Varies by prep
Safety rating
Use extra caution: Moderate caution
Best for
Cardiovascular, Stress resilience, Inflammatory signaling
Avoid / review if
Caution With Anticoagulants And Antiplatelets.
Generally well tolerated for most users.
Salvia Miltiorrhiza has a limited human evidence evidence level. It is categorized as preliminary with a mechanism-heavy evidence style.
Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.
Compare side-by-side tradeoffs or verify active marker guidelines.
Independent database mapping. Sourcing availability is evaluated separately from safety and clinical efficacy scores.
Affiliate Disclosure: Clicking verification or shopping links may earn this site a commission at no additional cost to you. Sourcing links are selected strictly based on quality criteria and availability, never based on commission tiers. Safety warnings and evidence ratings remain independent of sourcing.